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Abstract 24 
Aim: The Ultra High Risk (UHR) criteria, consisting of Brief Limited Intermittent Psychotic 25 
Symptoms (BLIPS), Attenuated Psychotic Symptoms (APS) and Genetic Risk and 26 
Deterioration Syndrome (GRD) are the most widely used criteria for assessing the At-Risk 27 
Mental State (ARMS) for psychosis. The Basel Screening Instrument for Psychosis (BSIP) 28 
includes a further risk category, the Unspecific Risk Category (URC). However, little is known 29 
about the predictive power of this risk category compared to other risk categories. 30 
Methods: Two hundred ARMS patients were detected as part of the FePsy (Früherkennung 31 
von Psychosen) study using the BSIP. Transition to psychosis was assessed in regular 32 
intervals for up to 7 years.   33 
Results: Patients meeting only the URC criterion (n = 40) had a significantly lower risk of 34 
transition to psychosis than the UHR group (including BLIPS, APS and GRD) (HR 0.19 [0.05; 35 
0.80] p=0.024*). Furthermore, the URC only risk group had a lower transition risk than the 36 
APS without BLIPS group (p= 0.015) and a trendwise lower risk than the BLIPS group 37 
(p=0.066). However, despite the lower transition risk in the URC only group, there were still 2 38 
patients (5%) in this group with a later transition to psychosis. 39 
Conclusions: The URC includes patients who have a lower risk of transition than those 40 
included by the UHR categories and thereby increases the sensitivity of the BSIP. This offers 41 
the possibility of a stratified intervention, with these subjects receiving low intensity follow up 42 
and treatment. 43 
KEYWORDS: follow-up studies; prodromal symptoms; psychotic disorders; risk; sensitivity 44 
and specificity  45 
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 46 
1. INTRODUCTION 47 
 48 
There is increasing evidence that intervention in a potential prodromal phase of psychosis 49 
can lead to improved outcomes in many domains (McGorry et al., 2009; Riecher-Rössler, 50 
McGorry, & Sartorius, 2016). Several clinical instruments have been developed to capture 51 
the potential prodromal phase of a psychotic disorder, leading to operationalized criteria for 52 
clinical high risk (CHR) or at-risk mental states (ARMS) (Fusar-Poli, Borgwardt, Bechdolf, & 53 
et al., 2013). The major approach to psychosis prediction in the last two decades was based 54 
on the Ultra High Risk criteria (UHR), focusing mainly on “prepsychotic symptoms” i.e., 55 
Attenuated Psychotic Symptoms (APS), Brief Limited Intermittent Psychotic Symptoms 56 
(BLIPS) and the so called “genetic risk and deterioration syndrome” (GRD); patients meeting 57 
UHR criteria show transition rates of up to 36% after 3 years of initial presentation (Fusar-58 
Poli, Bonoldi, Yung, & et al., 2012). Another important line of research has been the Basic 59 
Symptom (BS) approach, which focuses on subjectively perceived cognitive and sensory 60 
changes that are qualitatively different from positive psychotic symptoms (Klosterkötter, 61 
Hellmich, Steinmeyer, & Schultze-Lutter, 2001). These are thought to represent an earlier 62 
risk stage (Schultze-Lutter, Ruhrmann, Berning, Maier, & Klosterkötter, 2010). 63 
Instruments assessing psychosis risk based on UHR and BS criteria in help seeking patients 64 
show excellent sensitivity but only modest specificity, with high rates of false positives 65 
(Fusar-Poli et al., 2015). However, several studies have shown that this can be improved by 66 
integrating further clinical, neurobiological and environmental factors into prediction models 67 
(Riecher-Rössler & Studerus, 2017). For example, specific aspects of psychopathology, 68 
social decline, and neurocognitive impairment have shown to be suitable candidates for 69 
multidomain assessment and increase of predictive power (Cannon et al., 2016; Riecher-70 
Rössler et al., 2013; Riecher-Rössler et al., 2009).  71 
The Basel Screening Instrument for Psychosis (BSIP) was developed in the late 1990’s by 72 
(Riecher-Rössler et al., 2008) with the aim of identifying not only patients at “Ultra High Risk” 73 
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(i.e., suffering from BLIPS, APS or GRD) but also patients thought to be at lower risk 74 
because of having less specific prodromal symptoms and risk factors for psychosis. A 75 
combination of these factors constitutes the Unspecific Risk Category (URC) of the BSIP. 76 
Specifically, it consists of the nine DSM-III-R (Diagnostic and Statistical Manual of Mental 77 
Disorders, 3rd edition-Revised) (American Psychiatric Association, 1987) prodromal 78 
symptoms and other unspecific prodromal symptoms and risk factors found in previous 79 
studies (Riecher-Rössler et al., 2008; Riecher-Rössler et al., 2006). The BSIP thus allows to 80 
assess the UHR criteria following Yung et al. (1998) and in addition to that defines a low risk 81 
or unspecific risk category. The instrument has been demonstrated to have a high predictive 82 
validity and reliability (Riecher-Rössler et al., 2008) and ARMS patients identified by the 83 
BSIP have shown transition rates that are comparable to those reported by other groups 84 
(Riecher-Rössler et al., 2013; Riecher-Rössler et al., 2008). An English translation of the 85 
BSIP can be found in the supplementary material. 86 
The creation of the URC was based on research findings reporting that up to 73% of patients 87 
later diagnosed as having schizophrenia had shown unspecific or negative symptoms before 88 
manifesting overt psychotic symptoms (Häfner et al., 1998). However, many URC symptoms 89 
overlap with those of other mental disorders and therefore they lack specificity. It was 90 
hypothesized that a combination of these symptoms with other known risk factors (e.g., 91 
social decline, drug use, previous behavioral or psychiatric problems and/or genetic risk) 92 
could indicate an increased risk of psychosis in help seeking individuals. To date, the 93 
predictive accuracy of the URC and its single components remains unknown and the 94 
predictive performance of DSM-III-R prodromal symptoms has only been tested 95 
retrospectively in psychotic patients (Jackson, McGorry, & Dudgeon, 1995). 96 
Thus, the main objective of the study was to assess the predictive value of the URC of the 97 
BSIP for a later transition to psychosis as compared to the more widely established UHR 98 
criteria. A second goal was to assess the predictive performance of the individual items 99 
comprised in the URC. Due to the unspecific nature of the symptoms and risk factors 100 
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comprised in the URC, we hypothesized that patients meeting only the URC would show a 101 
lower risk of transition to psychosis than patients meeting any of the UHR criteria.  102 
 103 
2. METHODS  104 
2.1 Setting and recruitment  105 
Study participants were recruited between March 1, 2000 and May 31, 2017 as part of the 106 
prospective “Früherkennung von Psychosen” (FePsy; English: early detection of psychosis) 107 
study. A detailed description of the study design can be found elsewhere (Riecher-Rössler et 108 
al., 2007; Riecher-Rössler et al., 2009). In brief, patients suspected to be in their early 109 
(prodromal) phase of psychosis were referred to our specialized early detection clinic at the 110 
University of Basel Psychiatric Hospital, Switzerland. To encourage early, low threshold 111 
referrals, widespread information campaigns were performed during the study period 112 
targeting both potential referring professionals and lay people. Risk check-lists for referrals 113 
and self-screening instruments were developed and distributed as described in detail in 114 
previous publications (Müller et al., 2010; Riecher-Rössler et al., 2013). After complete 115 
description of the study to the subjects, written informed consent was obtained. The study 116 
was approved by the ethics committee of North-western and Central Switzerland (EKNZ) and 117 
conforms to the provisions of the declaration of Helsinki of 1975, as revised in 2008. 118 
Patients were included into this study if they met ARMS criteria (see below) and did not meet 119 
any of the following exclusion criteria: age below 18 years, insufficient knowledge of German, 120 
IQ < 70, previous episode of schizophrenic psychosis (treated with antipsychotics for >3 121 
weeks or exceeding lifetime cumulative chlorpromazine equivalent dose of 2500 mg), 122 
psychosis clearly due to organic reasons or substance abuse, or psychotic symptomatology 123 
within a clearly diagnosed affective psychosis or borderline personality disorder. 124 
 125 
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2.2 Screening 126 
All patients referred to our early detection center were screened with the Basel Screening 127 
Instrument for Psychosis (BSIP). A detailed description of the instrument can be found in a 128 
previous publication (Riecher-Rössler et al., 2008). The English version of the BSIP is 129 
available online as Supporting Information. Briefly, this instrument allows assessing pre-130 
psychotic and psychotic symptoms but also includes early prodromal symptoms as specified 131 
in the DSM-III-R (American Psychiatric Association, 1987) and other unspecific potential 132 
prodromal symptoms and risk factors for psychosis as reported in literature such as young 133 
age, drug abuse, psychoses in family members or social decline (Riecher-Rössler et al., 134 
2008; Riecher-Rössler et al., 2006). It includes 7 domains of symptoms, signs and risk 135 
factors. The BSIP has shown a good inter-rater reliability (κ = 0.67) for the assessment of the 136 
main outcome category “at-risk for psychosis” and a high predictive validity (Riecher-Rössler 137 
et al., 2008). 138 
Inclusion as ARMS patient occurred if one of the following criteria was met: (1) Prepsychotic 139 
category: APS or BLIPS according to criteria by Yung et al. (1998); (2) Genetic risk category 140 
(GRC): genetic risk in combination with 2 or more other risk factors such as social decline; 141 
(3) Unspecific Risk Category (URC): a certain combination of risk factors according to the 142 
screening instrument. A more precise description of the risk categories is accessible in the 143 
English version of the BSIP (see Supporting Information). Patients classified under 144 
categories (1) and (2) are considered at “high risk” because they show more psychosis-145 
related symptoms or risk factors, whereas patients in category (3) show rather unspecific 146 
symptoms and risk factors and are thus considered has having a “lower risk”.  147 
Patients were classified as having an ARMS, as not having an ARMS or as having an 148 
established first episode psychosis.  149 
 150 
 151 
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2.3 Assessment of current psychopathology 152 
In addition to screening with the BSIP, patients were examined on other aspects of 153 
psychopathology. Negative symptoms were assessed with the Scale for the Assessment of 154 
Negative Symptoms (SANS) (Andreasen, 1989) and positive and disorganized symptoms 155 
were examined with the Brief Psychiatric Rating Scale- Expanded version (BPRS- E) 156 
(Ventura et al., 1993). BPRS subscales were calculated according to the five-factor model 157 
recently proposed by Dazzi, Shafer, and Lauriola (2016). 158 
2.4 Follow up 159 
If patients fulfilled criteria for having an ARMS they were asked to take part in further multi-160 
domain assessments and in a follow-up study. Patients who agreed to participate were 161 
reassessed at regular intervals for up to 7 years to examine whether transition to psychosis 162 
had occurred. Transition to psychosis was assessed according to the criteria of Yung et al. 163 
(1998) using the four BPRS items “suspiciousness”, “unusual thought content”, 164 
“hallucinations” and “conceptual disorganization”. During the first year of the follow-up, 165 
ARMS patients were assessed monthly, during the second and third years every 3 months, 166 
and thereafter annually. 167 
2.5. Statistical analyses 168 
All analyses were performed using the R environment for statistical computing (R 169 
Development Core Team, 2017). The predictive potential of baseline sociodemographic and 170 
clinical variables, as well as of different risk groups, was investigated using survival analysis 171 
methods. Survival models are more appropriate than binary outcome (i.e., transition vs. non-172 
transition) models in prospective studies with longer-term diagnostic outcomes and regular 173 
follow-up assessments because they not only take transition vs. non-transition into account 174 
but also the time to transition and thus have more statistical power (van der Net et al., 2008). 175 
Furthermore, whereas binary outcome models must exclude patients with short follow-up 176 
duration, which leads to further reduced power and potentially unrepresentative samples, 177 
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survival models do not suffer from this problem because they can treat patients with 178 
incomplete follow-up as censored observations (i.e., patients can still provide information for 179 
estimating the probability of transition up to the time they were followed up). For binary and 180 
continuous independent variables, we used log-rank and cox proportional hazard models, 181 
respectively. 182 
Since the four risk criteria of the BSIP had large overlaps, we stratified study participants 183 
hierarchically based on the fulfillment of four non-overlapping conditions: 1) BLIPS; 2) APS, 184 
but not BLIPS; 3) GRD, but not APS or BLIPS; and 4) URC, but not BLIPS, APS, or GRD 185 
(i.e., URC only). We then performed log-rank tests to compare the rate of transition to 186 
psychosis between the URC only group and groups 1 to 3 individually and combined. 187 
 188 
3. RESULTS 189 
3.1 Baseline demographic and clinical characteristics 190 
745 patients with suspected ARMS were screened of whom 310 were identified as having an 191 
ARMS. Of these, 200 provided written informed consent and thus were included into this 192 
study. Forty-four (22%) of these patients transitioned to psychosis within the follow-up period 193 
(ARMS-T) and 156 did not (ARMS-NT). Mean follow-up time was 3.04 years (median 2.66, 194 
range 0.03-7.00) for ARMS-NT patients and 1.35 years (median 0.77, range 0.01-6.51) for 195 
ARMS-T patients. 196 
The frequencies of different risk categories, as well as their overlap, are presented in Figure 197 
1. All patients fulfilling APS or BLIPS criteria also met the URC criterion. Among those in the 198 
GRD category all except two also met the URC criterion. Forty (20%) patients were only 199 
included because they had a combination of unspecific risk factors, that is, because they met 200 
the URC only criterion. 201 
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Socio-demographic and clinical characteristics at baseline of the total study sample, as well 202 
as of ARMS-T and ARMS-NT patients, are shown in Table 1. None of the sociodemographic 203 
variables were significantly associated with later transition to psychosis. However, higher 204 
scores at baseline in the BPRS total score, in the BPRS subscales of “positive symptoms” 205 
and “disorganization” significantly increased the risk of transition to psychosis (p = 0.037, p = 206 
0.001 and p =0.011 respectively).   207 
When the sample of ARMS patients was stratified hierarchically (BLIPS, APS but not BLIPS, 208 
GRD but not APS or BLIPS, URC only), risk criteria were distributed as follows: 15 (7.5%) 209 
patients met the BLIPS criterion, 128 (64%) had APS but not BLIPS, 17 (8.5%) had GRD but 210 
not APS or BLIPS, and 40 (20%) met the URC only criterion (Table 2).  211 
3.2 Differences in transition rates across risk categories 212 
Patients meeting the URC only criterion had a significantly lower risk of transition to 213 
psychosis than all other risk groups combined (HR 0.19 [0.05; 0.80] p = 0.024*). 214 
Furthermore, the URC only risk group had a lower transition risk than the APS without BLIPS 215 
group (p = 0.015) and a trendwise lower risk than the BLIPS group (p = 0.066) (Table 2). 216 
Figure 2 shows the Kaplan-Meier estimates of the proportion of patients remaining non-217 
psychotic for each of the four risk categories (stratified hierarchically). 218 
3.3 Individual items of the URC 219 
Among the individual items comprised in the URC criterion, within the total group of all 220 
patients, only the item “ever experienced psychotic or attenuated psychotic symptoms” 221 
showed a significant increase of risk for transition to psychosis (HR 6.70 [1.62; 27.7] p = 222 
0.009**). The DSM-III-R prodromal symptom “odd beliefs” showed a trend towards increased 223 
risk (HR 1.76 [0.96; 3.21] p = 0.066). None of the other items seemed to significantly 224 
increase the risk individually. However, most of the items had a greater prevalence among 225 
subjects who later transitioned to psychosis than among those who did not transition (Table 226 
3). 227 
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4. DISCUSSION 228 
The present study investigated the predictive power for transition to psychosis of different 229 
ARMS categories identified with the BSIP in patients followed-up for up to 7 years. Recent 230 
studies have shown that the construct of ARMS is not homogeneous (Fusar-Poli et al., 2016) 231 
and that clinical staging or stratification of risk may be necessary to better plan and 232 
individualize treatment strategies (Cannon et al., 2016; Fusar-Poli, 2017). Accordingly, we 233 
found that high risk categories yielded very heterogeneous results regarding transition to 234 
psychosis. The fact that none of the patients meeting the GRD criterion (without APS or 235 
BLIPS) transitioned  to psychosis is in line with recent findings showing that this category 236 
may not be suitable for risk prediction, at least in the short-term, and that it should be viewed 237 
as a different class of risk (Fusar-Poli et al., 2016; Schultze-Lutter et al., 2015).The APS 238 
category is nowadays the most frequently found in ARMS samples and the most solidly 239 
supported risk category of the ARMS construct (Cornblatt & Carrion, 2016) and it is being 240 
used as the main category in novel clinical staging models (Carrion, Correll, Auther, & 241 
Cornblatt, 2017). In accordance with this, we found that APS was the most prevalent risk 242 
group in our sample of ARMS patients and that its presence significantly increased the risk of 243 
transition to psychosis.  244 
The main aim of the study, however, was to assess the predictive power of the URC criterion 245 
with regards to psychosis transition. We could confirm the hypothesis that this category 246 
included individuals with a considerably lower risk of transition than the UHR group. This is 247 
probably due to the fact that some of the symptoms and risk factors of the URC (e.g., social 248 
isolation, lack of initiative, impaired role functioning, drug use) are also important features of 249 
common mental disorders such as depression and anxiety (Horneland, Vaglum, & Larsen, 250 
2002). Nevertheless, it is well known that the prodromal phase of psychotic disorders is 251 
characterized by many of these unspecific symptoms (Häfner et al., 1998; Häfner, Riecher-252 
Rössler, Hambrecht, et al., 1992; Häfner, Riecher-Rössler, Maurer, Fätkenheuer, & Löffler, 253 
1992; Riecher-Rössler et al., 2006). Therefore, attributing these manifestations of 254 
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psychopathology to a possibly emerging psychotic illness can be a challenging task (Aston et 255 
al., 2012). The high rates of comorbidity in ARMS patients, especially with depressive 256 
disorders (Fusar-Poli, Nelson, Valmaggia, Yung, & McGuire, 2014), create a picture of mixed 257 
early subthreshold symptoms (some with psychotic expression), with some authors 258 
proposing a transdiagnostic model for the early assessment (Cuesta & Peralta, 2008; 259 
McGorry & Nelson, 2016; Riecher-Rössler & Studerus, 2017; van Os & Guloksuz, 2017). 260 
Additionally, in our sample, we could not demonstrate that any individual item comprising the 261 
URC was significantly associated with later transition to psychosis, except for the item “ever 262 
experienced psychotic or attenuated psychotic symptoms”. This may reflect the fact that this 263 
item is largely overlapping with APS or BLIPS risk criteria (i.e., patients meeting APS or 264 
BLIPS risk criteria also met the mentioned item of the URC, but not vice versa).  265 
Despite the lower specificity of these symptoms, we have recently shown that by including 266 
the URC the BSIP ensures not to miss any referred individual at-risk who later transitioned to 267 
frank psychosis (sensitivity of 1) at the cost of identifying more false positives (specificity of 268 
0.35) (Papmeyer et al., 2017). As shown in this study, among the patients included in the 269 
URC only category, 5% transitioned to psychosis, which is still not negligible considering that 270 
otherwise these patients would not have been identified as at-risk patients.  271 
Major strengths of the study are the long period of follow up compared to many of the UHR 272 
studies so that transitions could be seen up to seven years after initial assessment and the 273 
big sample size. The main limitation of the study is that the results shown provide the 274 
predictive performance of a certain risk category in comparison to others with a somehow 275 
artificial distinction of risk groups to avoid overlap of different categories.  276 
In conclusion, our results support the need for a more exact distinction of the components of 277 
the ARMS construct with different classes of risk guiding more specific interventions. 278 
Integrating the URC into the clinical staging model for psychotic and severe mood disorders 279 
as proposed by McGorry, Hickie, Yung, Pantelis, and Jackson (2006), we could assimilate 280 
this subgroup to the stage 1a (mild or non-specific symptoms). This stage represents a lower 281 
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grade of psychopathology compared to patients who meet the UHR criteria (stage 1b). The 282 
access to low-stigma services with psychoeducation, monitoring and low threshold 283 
interventions (e.g., substance abuse reduction, cognitive behavioral therapy) addressing the 284 
full range of early psychopathology and according to the individuals needs may be a useful 285 
strategy for these patients.  286 
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Table 1: Socio-demographic and clinical characteristics of the sample 424 
 425 
 All ARMS-NT
†
 ARMS-T Hazard Ratio 
p-value 
 N=200 N=156 N=44 [95% CI] 
Gender:      
    Women 62 (31.0%) 44 (28.2%) 18 (40.9%) Ref.  
    Men 138 (69.0%) 112 (71.8%) 26 (59.1%) 0.67 [0.37;1.23] 0.194 
Age 25.1 (6.9) 24.9 (7.0) 25.8 (6.5) 1.00 [0.97;1.04] 0.818 
Years of education 11.7 (2.8) 11.9 (2.9) 11.1 (2.4) 0.90 [0.81;1.01] 0.079° 
BPRS Activation 3.8 (1.5) 3.8 (1.5) 3.9 (1.7) 1.06 [0.89;1.27] 0.501 
BPRS Positive Symptoms 5.5 (2.1) 5.3 (2.1) 6.3 (2.0) 1.24 [1.09;1.42] 0.001*** 
BPRS Negative Symptoms 5.5 (2.7) 5.4 (2.6) 5.7 (2.9) 0.99 [0.89;1.11] 0.888 
BPRS Affect 6.8 (2.8) 6.7 (2.9) 7.0 (2.7) 1.03 [0.93;1.14] 0.590 
BPRS Disorganization 3.9 (1.3) 3.8 (1.2) 4.4 (1.7) 1.27 [1.05;1.52] 0.011* 
BPRS total score 39.3 (8.8) 38.6 (8.5) 41.8 (9.4) 1.03 [1.00;1.07] 0.037* 
SANS total score 21.5 (16.1) 20.6 (16.3) 24.7 (15.0) 1.01 [0.99;1.03] 0.269 
For gender, absolute numbers with percentages in parenthesis are reported. For all other variables 
means with standard deviations in parenthesis are reported. ARMS-NT = at-risk mental state without 
later transition to psychosis; ARMS-T = at-risk mental state with later transition to psychosis; CI = 
confidence interval; BPRS = Brief Psychiatric Rating Scale (Ventura et al., 1993); SANS = Scale for 
the Assessment of Negative Symptoms (Andreasen, 1989). 
° p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001
†
 66 of these patients had a follow-up duration of less 
than 2 years and hence can only be tentatively called ARMS-NT patients. However, since associations 
with later transition to psychosis were tested with survival analyses, which can accommodate for short 
follow-up durations, significance estimates should still be accurate. 
 426 
 427 
 428 
 429 
 430 
 431 
 432 
 433 
 434 
 435 
  436 
Table 2: Psychosis risk comparison for different risk categories using survival analysis. 437 
 All ARMS-NT
†
 ARMS-T Hazard Ratio 
p-value 
 N=200 N=156 N=44 [95% CI] 
Risk group:      
    BLIPS 15 (7.5%) 11 (7.1%) 4 (9.1%) 4.93 [0.90;27.0]
‡
 0.066° 
    APS, but not BLIPS 128 (64.0%) 90 (57.7%) 38 (86.4%) 5.84 [1.41;24.2]
‡
 0.015* 
    GRD, but not APS or BLIPS 17 (8.5%) 17 (10.9%) 0 (0.0%) 0.00 [0.00;]
‡
 0.997 
URC only 40 (20.0%) 38 (24.4%) 2 (4.5%) 0.19 [0.05;0.80]
§
 0.024* 
ARMS-NT = at-risk mental state without later transition to psychosis; ARMS-T = at-risk mental state with later transition to psychosis; CI = 
confidence interval; APS = attenuated psychotic symptoms; BLIPS = brief limited intermittent psychotic symptoms; GRD = genetic risk and 
deterioration syndrome; URC = unspecific risk category. 
° p < 0.1, * p < 0.05
† 
66 of these patients had a follow-up duration of less than 2 years and hence can only be tentatively called ARMS-NT 
patients. However, since associations with later transition to psychosis were tested with survival analyses, which can accommodate for short 
follow-up durations, significance estimates should still be accurate. 
‡ 
When compared to the URC only group 
§
 When compared to all other risk groups combined 
 
  438 
Table 3: Predictive values of items comprised in the URC criterion of the BSIP in the total 439 
sample 440 
 441 
 ARMS-NT
†
 ARMS-T Hazard Ratio 
p-value N
‡
 
 N=156 N=44 [95% CI] 
Male < 25 years or female < 30 years 10 (69.2%) 27 (61.4%) 0.78 [0.42;1.43] 0.421 200 
Social isolation 82 (52.9%) 24 (57.1%) 1.29 [0.70;2.39] 0.411 197 
Impaired role functioning 107 (69.9) 32 (74.4%) 1.29 [0.65;2.56] 0.468 196 
Peculiar behavior
§ 
20 (12.9%) 3 (7.0%) 0.54 [0.17;1.75] 0.304 198 
Impairment in personal hygiene 23 (14.9%) 10 (23.3%) 1.69 [0.83;3.44] 0.145 197 
Blunted or inappropriate affect 73 (49.0%) 20 (48.8%) 1.15 [0.62;2.12] 0.665 190 
Disturbances of speech
§
 29 (18.8%) 8 (19.5%) 1.04 [0.48;2.26] 0.917 195 
Odd beliefs
§
 45 (29.2%) 21 (48.8%) 1.78 [0.97;3.24] 0.061° 197 
Unusual perceptual experiences
§
  60 (39.5%) 21 (48.8%) 1.28 [0.70;2.32] 0.425 195 
Lack of initiative 108 (69.7) 32 (78.0%) 1.59 [0.76;3.34] 0.223 196 
Other unspecific prodromal signs 135 (86.5) 34 (79.1%) 0.72 [0.35;1.50] 0.382 199 
Ever experienced psychotic or 
attenuated psychotic symptoms
§
 
109 (69.9) 42 (95.5%) 6.70 [1.62;27.7]    0.009** 200 
Social decline
§ 
112 (73.2) 31 (72.1%) 1.05 [0.54;2.05] 0.878 196 
Drug use (regularly in the last 2 years) 67 (43.2%) 21 (48.8%) 1.41 [0.78;2.57] 0.258 198 
Previous psychiatric disease 96 (62.7%) 20 (47.6%) 0.62 [0.34;1.13] 0.119 195 
Suspected or confirmed psychosis in 
first-degree relative 
24 (18.2%) 8 (19.5%) 1.02 [0.47;2.22] 0.954 173 
Confirmed psychosis in second-
degree relative 
24 (18.5%) 3 (7.3%) 0.44 [0.13;1.42] 0.168 171 
Referral with suspected psychosis 95 (79.8%) 18 (66.7%) 0.63 [0.28;1.41] 0.262 146 
BSIP = Basel Screening Instrument for Psychosis; ARMS-NT = at-risk mental state without later 
transition to psychosis; ARMS-T = at-risk mental state with later transition to psychosis; CI = 
confidence interval; APS = attenuated psychotic symptoms; BLIPS = brief limited intermittent 
psychotic symptoms; URC = unspecific risk category. 
° p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001 
† 
66 of these patients had a follow-up duration of less than 2 years and hence can only be tentatively 
called ARMS-NT patients. However, since associations with later transition to psychosis were tested 
with survival analyses, which can accommodate for short follow-up durations, significance estimates 
should still be accurate. 
‡
 Number of cases with non-missing information  
§
 Highly specific items according to the BSIP. 
 442 
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FIGURE LEGENDS 444 
Figure 1. Venn diagram showing number of cases fulfilling criteria for attenuated psychotic 445 
symptoms (APS), brief limited intermittent psychotic symptoms (BLIPS), genetic 446 
risk and deterioration syndrome (GRD) and the unspecific risk category (URC) at 447 
baseline assessment. 448 
Figure 2. Kaplan-Meier estimates of proportions of individuals remaining non-psychotic over 449 
time stratified for different risk criteria. 450 
